EA201001032A1 - Таблетки с пленочным покрытием, содержащие в качестве активного компонента дроспиренон, и способ их получения - Google Patents

Таблетки с пленочным покрытием, содержащие в качестве активного компонента дроспиренон, и способ их получения

Info

Publication number
EA201001032A1
EA201001032A1 EA201001032A EA201001032A EA201001032A1 EA 201001032 A1 EA201001032 A1 EA 201001032A1 EA 201001032 A EA201001032 A EA 201001032A EA 201001032 A EA201001032 A EA 201001032A EA 201001032 A1 EA201001032 A1 EA 201001032A1
Authority
EA
Eurasian Patent Office
Prior art keywords
active component
tablets
drospirenon
obtaining
film coating
Prior art date
Application number
EA201001032A
Other languages
English (en)
Other versions
EA017869B1 (ru
Inventor
Аттила Бодиш
Иштван Греинер
Каса Йонатан Михай Надь
Original Assignee
Рихтер Гедеон Нирт.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рихтер Гедеон Нирт. filed Critical Рихтер Гедеон Нирт.
Publication of EA201001032A1 publication Critical patent/EA201001032A1/ru
Publication of EA017869B1 publication Critical patent/EA017869B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Abstract

Изобретение относится к таблетке с пленочным покрытием, содержащей дроспиренон и обладающей улучшенной стойкостью к воздействию факторов окружающей среды, в особенности атмосферной влажности. Кроме того, изобретение относится к способу получения сердцевин (ядро) таблеток с пленочным покрытием, в котором нанесение активного компонента на сердцевину может быть осуществлено при повышенном уровне безопасности.
EA201001032A 2007-12-20 2008-09-02 Таблетки с пленочным покрытием, содержащие в качестве активного компонента дроспиренон, и способ их получения EA017869B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0700826A HUP0700826A3 (en) 2007-12-20 2007-12-20 Coated tablet containing drospirenone and process for producing the same
PCT/HU2008/000100 WO2009081216A1 (en) 2007-12-20 2008-09-02 Film coated tablets containing drospirenone as active agent and a method for the preparation thereof

Publications (2)

Publication Number Publication Date
EA201001032A1 true EA201001032A1 (ru) 2010-12-30
EA017869B1 EA017869B1 (ru) 2013-03-29

Family

ID=89987951

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001032A EA017869B1 (ru) 2007-12-20 2008-09-02 Таблетки с пленочным покрытием, содержащие в качестве активного компонента дроспиренон, и способ их получения

Country Status (23)

Country Link
US (1) US20110002993A1 (ru)
EP (2) EP2072041B1 (ru)
JP (1) JP5679819B2 (ru)
CN (1) CN101896166B (ru)
AU (1) AU2008339588B2 (ru)
BR (1) BRPI0820450A2 (ru)
CA (1) CA2708875A1 (ru)
CY (1) CY1113416T1 (ru)
DK (1) DK2072041T3 (ru)
EA (1) EA017869B1 (ru)
ES (1) ES2391953T3 (ru)
HK (1) HK1147054A1 (ru)
HR (1) HRP20120815T1 (ru)
HU (1) HUP0700826A3 (ru)
IL (1) IL205818A (ru)
MY (1) MY148138A (ru)
NZ (1) NZ585554A (ru)
PL (1) PL2072041T3 (ru)
PT (1) PT2072041E (ru)
SI (1) SI2072041T1 (ru)
UA (1) UA103182C2 (ru)
WO (1) WO2009081216A1 (ru)
ZA (1) ZA201003913B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160048305A1 (en) * 2014-08-14 2016-02-18 Microsoft Corporation Group-Based User Interface Rearrangement
JP7041120B2 (ja) * 2016-08-04 2022-03-23 ビーピーエスアイ ホールディングス， エルエルシー 飲み込み易い被膜及びそれにより被覆された基材
CN111655147A (zh) * 2018-01-29 2020-09-11 普和希控股公司 生物传感器探针用保护膜材料
WO2019176339A1 (ja) * 2018-03-13 2019-09-19 Ｐｈｃホールディングス株式会社 バイオセンサプローブ用保護膜材料

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE3022337A1 (de) 1980-06-11 1982-01-07 Schering Ag Berlin Und Bergkamen, 1000 Berlin Praeparate zur kontrazeption und zur behandlung gynaekologischer stoerungen
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
JP4354667B2 (ja) 1999-08-31 2009-10-28 バイエル・シエーリング・ファーマ・アクチエンゲゼルシャフト 避妊薬としての使用へのエチニルエストラジオールとドロスピレノンの医薬用組合せ
US20020132801A1 (en) * 2001-01-11 2002-09-19 Schering Aktiengesellschaft Drospirenone for hormone replacement therapy
EP1216713A1 (en) * 2000-12-20 2002-06-26 Schering Aktiengesellschaft Compositions of estrogen-cyclodextrin complexes
JP2004315713A (ja) * 2003-04-18 2004-11-11 Shin Etsu Chem Co Ltd 非イオン性セルロースエーテルの製造方法及びこれにより得られる非イオン性セルロースエーテル造粒物
EP1625849A1 (en) * 2004-08-09 2006-02-15 Liconsa, Liberacion Controlada de Sustancias Activas, S.A. Pharmaceutical composition comprising drospirenone and ethynylestradiol
US8475838B2 (en) * 2005-06-03 2013-07-02 Sandoz Ag Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
EP1767194A1 (de) * 2005-06-09 2007-03-28 Helm AG Verfahren zur Herstellung von Adsorbaten des Drospirenons

Also Published As

Publication number Publication date
AU2008339588A1 (en) 2009-07-02
CN101896166A (zh) 2010-11-24
ZA201003913B (en) 2011-03-30
PT2072041E (pt) 2012-10-31
JP2011507825A (ja) 2011-03-10
IL205818A0 (en) 2010-11-30
SI2072041T1 (sl) 2012-11-30
NZ585554A (en) 2012-06-29
EP2446880A1 (en) 2012-05-02
WO2009081216A1 (en) 2009-07-02
US20110002993A1 (en) 2011-01-06
MY148138A (en) 2013-02-28
PL2072041T3 (pl) 2012-12-31
HRP20120815T1 (hr) 2012-11-30
EP2072041A1 (en) 2009-06-24
JP5679819B2 (ja) 2015-03-04
AU2008339588B2 (en) 2014-06-26
IL205818A (en) 2016-05-31
EP2072041B1 (en) 2012-08-01
HUP0700826A2 (en) 2009-07-28
BRPI0820450A2 (pt) 2015-06-16
HUP0700826A3 (en) 2010-03-29
CA2708875A1 (en) 2009-07-02
DK2072041T3 (da) 2012-11-05
HK1147054A1 (en) 2011-07-29
UA103182C2 (ru) 2013-09-25
ES2391953T3 (es) 2012-12-03
EA017869B1 (ru) 2013-03-29
HU0700826D0 (en) 2008-02-28
CN101896166B (zh) 2013-05-01
CY1113416T1 (el) 2016-06-22

Similar Documents

Publication Publication Date Title
AR114143A2 (es) Formulaciones de comprimidos revestidos
CY1111729T1 (el) Υπογλωσσιο επικαλυμμενο δισκιο
NZ709512A (en) Process for producing a coated packaging material and packaging material having at least one barrier layer for hydrophobic compounds
WO2010080618A3 (en) Porous reactive frameworks
EP2236283A4 (en) MEMBERS WITH A CORROSION-RESISTANT COATING FILM, METHOD FOR THE PRODUCTION THEREOF AND COATING COMPOSITION FOR THE PRODUCTION THEREOF
WO2010078325A3 (en) Natriuretic polypeptides for reducing or preventing restenosis
SG171542A1 (en) Pharmaceutical composition comprising a strontium salt, vitamin d and a cyclodextrin
ECSP11010812A (es) Complejo de mineral-aminoácido polisacárido
EP2399168A4 (en) CHEMICAL AMPLIFICATION RESERVE COMPOSITION, AND MOLD PREPARATION METHOD, AND RESERVE FILM USING THE SAME
EP2053036A4 (en) ORGANORUHENIC COMPLEX AND PROCESS FOR PRODUCING RUTHENIUM THIN FILM USING THE RUTHENIC COMPELX
WO2008115890A3 (en) Mapk/erk kinase inhibitors
EP2479226A4 (en) POROUS STRUCTURE FOR FORMING A FINGERPRINT-RESISTANT COATING, METHOD FOR FORMING A FINGERPRINT-RESISTANT COATING WITH THE POROUS STRUCTURE, SUBSTRATE WITH THE FINGERPRINT-RESISTANT COATING MADE IN THIS PROCESS AND PRODUCTS WITH THE SUBSTRATE
BR112014001620A2 (pt) composição de revestimento, película fina anti-impressão digital, e produto eletrônico
ATE555156T1 (de) Sauerstofffänger-mischungen
EP2336253A4 (en) AQUEOUS COATING COMPOSITIONS, PROCESS FOR PRODUCING THE SAME, AND PROCESS FOR PRODUCING COATING FILM
WO2012067349A3 (ko) 고분자 화합물 및 이를 포함하는 액침 노광 프로세스용 레지스트 보호막 조성물
MY161601A (en) Films and compositions comprising the same
MX2009004269A (es) Inhibidores de cinasa mapk/erk.
EA201001032A1 (ru) Таблетки с пленочным покрытием, содержащие в качестве активного компонента дроспиренон, и способ их получения
WO2012106680A8 (en) Methods and compositions for chemical drying and producing struvite
GB2487130B (en) Bilayer systems including a polydimethylglutarimide-based bottom layer and compositions thereof
WO2011051967A3 (en) Pharmaceutical compositions comprising mycophenolate and processes for preparing thereof
BRPI0823125A2 (pt) Artigo de acondicionamento, método, e, composicao sequestrante de oxigênio.
MX2008009830A (es) Efecto del inhibidor bst2.
WO2012032155A3 (en) Improved brass alloy and a method of manufacturing thereof